15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Arko Corp, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $7.00 to $7.00, so the covering firms are broadly aligned. The average target of $7.00 sits 49% above the current $4.71. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near -5% this year and 2% next, consensus EPS building from about $0.00 next quarter toward $0.13 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Arko Corp.
As of Sep, 1 of 1 firms rate ARKO a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ARKO EPS & revenue forecast
EPS · NEXT QUARTER
$0.00
Range $0.00 – $0.00 · 1 analysts
Next period, 1 analysts expect Arko Corp to earn $0.00 a share (range $0.00 – $0.00), versus $0.00 a year earlier. Full-year consensus is $0.11, growing to $0.13 the year after.
REVENUE · NEXT QUARTER
$1.8B
Range $1.7B – $1.8B · 1 analysts · -7% YoY
Revenue is expected to reach $1.8B (range $1.7B – $1.8B), -7.0% year-over-year. Full-year consensus is $7.7B, rising to $7.4B next year.
Top analysts covering Arko Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ARKO.
#1
Bobby Griffin
Raymond James
Buy
$7.00+48.8% to target
Coverage
—
+ Follow
#2
Kelly Bania
BMO Capital
Hold
$5.00+6.3% to target
Coverage
—
+ Follow
#3
MA
Mark Astrachan
Stifel
Hold
$7.50+59.4% to target
Coverage
—
+ Follow
ARKO stock forecast FAQ
What is ARKO's average 12-month price target?+
The 1 analysts with a live target average $7.00 for Arko Corp over the next 12 months, ranging from a $7.00 high to a $7.00 low.
Is ARKO stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover ARKO?+
1 analysts have an active rating on Arko Corp, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering ARKO?+
Among analysts who currently cover ARKO, Bobby Griffin of Raymond James has the strongest overall Quantellect track record. Their current call is Buy with a $7.00 target.
What is Arko Corp's projected EPS for next quarter?+
The consensus estimate is $0.00 per share (range $0.00 – $0.00) across 1 analysts. Full-year EPS is projected at $0.11, rising to $0.13 the following year.
How much revenue is Arko Corp expected to report next quarter?+
Consensus revenue is $1.8B (range $1.7B – $1.8B). Full-year revenue is projected at $7.7B, growing to $7.4B next year.
Have analysts been upgrading or downgrading ARKO lately?+
As of Sep, 1 of 1 firms rate ARKO a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ARKO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
